We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Metropolitan Health Networks, Inc. | NYSE:MDF | NYSE | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.26 | 0.00 | 01:00:00 |
NEW YORK, Nov. 9, 2012 /PRNewswire/ --
Kayak Software Corporation
Levi & Korsinsky is investigating the Board of Directors of Kayak Software Corporation (NasdaqGS: KYAK) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to priceline.com Incorporated (NasdaqGS: PCLN) under which shareholders would receive cash and stock valued at approximately $40 per share.
Click here to learn more about the investigation: http://zlk.9nl.com/kayak-software-kyak, or call: 877-363-5972.
(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)
First California Financial Group, Inc.
Levi & Korsinsky is investigating the Board of Directors of First California Financial Group, Inc. (Nasdaq: FCAL) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to PacWest Bancorp (Nasdaq: PACW) for stock valued at approximately $8 per share.
Click here to learn more about the investigation: http://zlk.9nl.com/first-california-financial-fcal, or call: 877-363-5972.
Metropolitan Health Networks, Inc.
Levi & Korsinsky is investigating the Board of Directors of Metropolitan Health Networks, Inc. (NYSE: MDF) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Humana Inc. (NYSE: HUM) for $11.25 per share. At least one analyst set a price target for Metropolitan stock at $13.00 per share.
Click here to learn more about the investigation: http://zlk.9nl.com/metropolitan-health-networks-mdf, or call: 877-363-5972.
DUSA Pharmaceuticals Inc.
Levi & Korsinsky is investigating the Board of Directors of DUSA Pharmaceuticals Inc. (Nasdaq: DUSA) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Sun Pharmaceutical Industries Limited (Reuters: SUN.BO) for $8 per share.
Click here to learn more about the investigation: http://zlk.9nl.com/dusa-pharmaceuticals-dusa, or call: 877-363-5972.
Levi & Korsinsky is a national firm with offices in New York and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
SOURCE Levi & Korsinsky, LLP
Copyright 2012 PR Newswire
1 Year Metropolitan Health Networks, Inc. Chart |
1 Month Metropolitan Health Networks, Inc. Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions